scholarly journals Analysis of the Factors Affecting the Reasons of Transition From Peritoneal Dialysis to Hemodialysis

2021 ◽  
Vol 30 (3) ◽  
pp. 230-234
Author(s):  
Sumeyra Koyuncu ◽  
◽  
Ali Gundogdu ◽  
Cihan Uysal ◽  
Ismail Kocyigit ◽  
...  
Keyword(s):  
Peritoneal Dialysis ◽  
Factors Affecting

Subcutaneous Cuff Migrates after Initiation of Peritoneal Dialysis

2018 ◽  
Vol 38 (3) ◽  
pp. 229-231
Author(s):  
Tsutomu Sakurada ◽  
Hitoshi Kotake ◽  
Kenichiro Koitabashi ◽  
Yugo Shibagaki
Keyword(s):  
Diabetes Mellitus ◽  
Peritoneal Dialysis ◽  
Retrospective Study ◽  
Site Infection ◽  
Background Characteristics ◽  
Single Center ◽  
Exit Site ◽  
Exit Site Infection ◽  
Factors Affecting ◽  
History Of

The aim of this study was to determine whether subcutaneous cuffs migrate toward the exit site after initiation of peritoneal dialysis (PD) and to clarify the factors affecting such migration. Subcutaneous cuff migration was defined as extension of the length of the external catheter. In this single-center, retrospective study, the external catheter lengths at initiation and 1 year later were compared in 33 PD patients (median age 62 years; 64% men; 49% with diabetes mellitus). The correlations between patient background characteristics at initiation and extension of catheter length were also examined. The external catheter length was significantly extended at 1 year later (13.5 vs 15.0 cm, p < 0.001). There was no relationship between a history of exit-site infection and extension of catheter length ( p = 0.250). Hemoglobin (r = -0.447, p = 0.009), serum albumin (r = -0.377, p = 0.031), and external catheter length at initiation (r = -0.350, p = 0.046) showed negative correlations with extension. In conclusion, subcutaneous cuff migration was observed in just 1 year and may be associated with malnutrition, anemia, and short external catheter length at initiation of PD.

Factors affecting peritoneal dialysis selection in Taiwanese patients with chronic kidney disease

2011 ◽  
Vol 58 (4) ◽  
pp. 463-469 ◽  
Author(s):  
C.-H. Liang ◽  
C.-Y. Yang ◽  
K.-C. Lu ◽  
P. Chu ◽  
C.-H. Chen ◽  
...  
Keyword(s):  
Chronic Kidney Disease ◽  
Peritoneal Dialysis ◽  
Kidney Disease ◽  
Factors Affecting

Subcutaneous Epoetin Beta in Renal Anemia: An Open Multicenter Dose Titration Study of Patients on Continuous Peritoneal Dialysis

1995 ◽  
Vol 15 (1) ◽  
pp. 54-60 ◽  
Author(s):  
Peter Bárány ◽  
Naomi Clyne ◽  
Britta Hylander ◽  
Ann-C. Johansson ◽  
Ole Simonsen ◽  
...  
Keyword(s):  
Peritoneal Dialysis ◽  
Hemoglobin Concentration ◽  
Dose Titration ◽  
Factors Affecting ◽  
Epoetin Beta ◽  
Moderate Anemia ◽  
Continuous Peritoneal Dialysis ◽  
The Mean ◽  
One Year ◽  
Beta Dose

Objective To establish dose requirements (target hemoglobin >100 g/L) and safety of subcutaneously administered epoetin beta. Design Open multicenter study. Patients Forty-five anemic patients (21 female, 24 male; mean age 55 years; range 20 79 years) who had been on continuous peritoneal dialysis for 1-157 months (mean 24 months). Thirty patients required blood transfusions during the year prior to the study. Mean hemoglobin concentration pretreatment was 75 g/L (range 57 –89 g/L). Intervention After a pretreatment period of two weeks, 60 IU kg-1 week-1 divided into three weekly doses of epoetin beta was administered subcutaneously. The dose was increased by 60 IU kg-1 week-1 after ten weeks, and when necessary, every fourth week in patients with hemoglobin levels below 100 g/L. Main Outcome Measures Hemoglobin concentration. Analysis of factors affecting the response to epoetin beta. Safety of epoetin beta. Results Thirty-eight of the 45 patients completed six months and 21 patients completed one year in the study. Twenty-six patients reached hemoglobin 100 g/L within six months and 8 patients did later on. The mean hemoglobin concentration after three months was 93 g/L (range 64 –144 g/L) and after six months was 99 g/L (range 59 –130 g/L; mean epoetin beta dose 1221U kg-1 week-I). During the second six-month period of the study, hemoglobin levels were stable in most patients. After one year, the mean hemoglobin was 110 g/L (range 84 –153 g/L) and the mean epoetin beta dose was 1071U kg-1 week-l. Prolonged correction time and impaired response to epoetin were observed in patients with infections or hemorrhages and in patients with low hemoglobin concentration before starting epoetin treatment. Iron deficiency was controlled by iron supplementation, either orally or, in 10 patients, intravenously. Increased blood pressure, requiring intensified antihypertensive treatment, was observed in 13 patients. Conclusions Continuous peritoneal dialysis patients with moderate anemia (Hb 75 –90 g/L) and without complicating disorders can be managed with subcutane0usdoses of ep0etin<1201U kg-lweek-l. Theepoetin beta dose should be adjusted after the first month of treatment since most patients required higher doses than the initial 60 IU kg-1 week-l.

Factors Affecting Ul Trafil Tration in Continuous Ambulatory Peritoneal Dialysis First Report of an International Cooperative Study

1984 ◽  
Vol 4 (1) ◽  
pp. 14-19 ◽  
Keyword(s):  
Peritoneal Dialysis ◽  
Continuous Ambulatory Peritoneal Dialysis ◽  
Cooperative Study ◽  
Mean Values ◽  
Factors Affecting ◽  
First Report ◽  
The Usa ◽  
Chronic Use

In 20 participating centers in Canada, France and the USA, 210 patients on continuous ambulatory peritoneal dialysis for one to 66 months underwent drainage measurements with a hypertonic (3.86 to 4.5 gm % dextrose), 2L, four-hour-dwell exchange. Patients had used lactate solutions only (n = 73), acetate solutions only (n = 21), or acetate before a change to lactate (n = 16). Mean net ultrafiltration (± SEM) (UF, ml) values were 701 ± 22, 489 ± 61, and 390 ± 56 respectively; mean dialysate glucose concentrations (mg/dl) were 1053 ± 23, 722 ± 107, and 701 ± 24. Mean values in groups exposed to acetate were significantly (p < 0.01) below those in the lactate-only group. There was no significant correlation of UF with the peritonitis rate; in the lactate-only group, there was no significant correlation between UF and time on CAPD. In summary, the chronic use of acetate solutions appeared to be associated with more rapid decreases in dialysate glucose and low UF Slingeneyer et al reported that 10 and 30% of patients treated with continuous ambulatory peritoneal dialysis (CAPD) at their center in France lose ultrafiltration capacity at one and two years respectively (I). Eventually 24% of patients with decreasing ultrafiltration had to be transferred to hemodialysis.

Sign in / Sign up

Export Citation Format

Share Document